Home
About
Overview
Sharing Data
ORCID
Help
History (0)
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Reder, Anthony T.
One or more keywords matched the following items that are connected to
Reder, Anthony T.
Item Type
Name
Concept
Immunosuppressive Agents
Academic Article
Fingolimod for the treatment of relapsing multiple sclerosis.
Academic Article
Immunoglobulin-like transcript 3, an inhibitor of T cell activation, is reduced on blood monocytes during multiple sclerosis relapses and is induced by interferon beta-1b.
Academic Article
Cystoid macular edema associated with fingolimod use for multiple sclerosis.
Academic Article
Ophthalmic evaluations in clinical studies of fingolimod (FTY720) in multiple sclerosis.
Academic Article
Varicella-zoster virus infections in patients treated with fingolimod: risk assessment and consensus recommendations for management.
Academic Article
Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial.
Academic Article
First-dose effects of fingolimod: Pooled safety data from three phase 3 studies.
Academic Article
The Direct Effects of Fingolimod in the Central Nervous System: Implications for Relapsing Multiple Sclerosis.
Academic Article
Immunologic mechanisms of fingolimod and the role of immunosenescence in the risk of cryptococcal infection: A case report and review of literature.
Academic Article
Dimethyl fumarate-induced changes in the MS lymphocyte repertoire: No need for subset monitoring.
Academic Article
Disability improvement as a clinically relevant outcome in clinical trials of relapsing forms of multiple sclerosis.
Academic Article
COVID-19 in Patients with Multiple Sclerosis: Associations with Disease-Modifying Therapies.
Academic Article
Medications for Multiple Sclerosis and Risk of Malignancy: What Next?
Academic Article
Increased Percentage of CD8+CD28- Regulatory T Cells With Fingolimod Therapy in Multiple Sclerosis.
Academic Article
Effectiveness of rituximab versus oral immunosuppressive therapies in neuromyelitis optica spectrum disorder in a racially diverse cohort of subjects: A single-center retrospective study.
Search Criteria
Immunosuppressive Agents